White Paper

It Hasn't Been Easy For Pharma To Be Green

Source: Asymchem
Go Green & Make Green

CDMOs At The Forefront of Green Chemistry Are Helping To Change That.

The pharmaceutical industry is under intense pressure to reduce the environmental harm caused by drug development and manufacturing. Many companies have created new mandates for greener, more sustainable processes internally, and have extended those mandates to their CDMO partners. A few of these CDMOs are now at the forefront of green chemistry, applying its principles to reduce the environmental and human impact of pharmaceutical production.

Biotech companies need to think green as well. Most of the drugs coming to market today are acquired by large or mid-size pharma companies from small biotech companies. Partnering with a CDMO proficient in green chemistry and manufacturing can help a biotech create the most attractive drug package – one that includes a proven commercialization process minimizing toxic waste that pose safety concerns or require costly remediation.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma